Bionoid Pharma, Inc.
BINP · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | – | – | $10 |
| Short-Term Investments | $0 | – | – | $0 |
| Receivables | $0 | – | – | $0 |
| Inventory | $0 | – | – | $0 |
| Other Curr. Assets | $0 | – | – | $50 |
| Total Curr. Assets | $0 | – | – | $61 |
| Property Plant & Equip (Net) | $0 | – | – | $0 |
| Goodwill | $0 | – | – | $0 |
| Intangibles | $4,078 | – | – | $4,527 |
| Long-Term Investments | $0 | – | – | $0 |
| Tax Assets | $0 | – | – | $0 |
| Other NC Assets | $0 | – | – | $0 |
| Total NC Assets | $4,078 | – | – | $4,527 |
| Other Assets | $0 | – | – | $0 |
| Total Assets | $4,078 | – | – | $4,588 |
| Liabilities | – | – | – | – |
| Payables | $0 | – | – | $5 |
| Short-Term Debt | $16 | – | – | $155 |
| Tax Payable | $0 | – | – | $0 |
| Deferred Revenue | $0 | – | – | $0 |
| Other Curr. Liab. | $134 | – | – | $0 |
| Total Curr. Liab. | $150 | – | – | $160 |
| LT Debt | $0 | – | – | $0 |
| Deferred Rev, NC | $0 | – | – | $0 |
| Deferred Tax Liab, NC | $0 | – | – | $0 |
| Other NC Liab. | $0 | – | – | $0 |
| Total NC Liab. | $0 | – | – | $0 |
| Other Liabilities | $0 | – | – | $0 |
| Cap. Leases | $0 | – | – | $0 |
| Total Liabilities | $150 | – | – | $160 |
| Equity | – | – | – | – |
| Pref Stock | $10 | – | – | $10 |
| Common Stock | $5 | – | – | $5 |
| Retained Earnings | -$19,951 | – | – | -$20,910 |
| AOCI | $0 | – | – | $0 |
| Other Equity | $23,863 | – | – | $25,322 |
| Total Equity | $3,927 | – | – | $4,428 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | – | – | $0 |
| Total Liab. & Tot. Equity | $4,078 | – | – | $4,588 |
| Net Debt | $16 | $0 | $0 | $145 |